Pharmocann Global (XTAE:PMCN-M) EBIT per Share : ₪-4.56 (TTM As of Jun. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Pharmocann Global EBIT per Share?

Pharmocann Global's EBIT per Share for the six months ended in Jun. 2024 was ₪-0.44. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-4.56.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Pharmocann Global's EBIT per Share or its related term are showing as below:

During the past 12 years, the highest 3-Year average EBIT per Share Growth Rate of Pharmocann Global was 147.50% per year. The lowest was -10.00% per year. And the median was 61.90% per year.

XTAE:PMCN-M's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 6.8
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Pharmocann Global's EBIT for the six months ended in Jun. 2024 was ₪-0.90 Mil.

Pharmocann Global EBIT per Share Historical Data

The historical data trend for Pharmocann Global's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmocann Global EBIT per Share Chart

Pharmocann Global Annual Data

Trend

Dec09

Dec10

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-77.95

9.41

-32.90

-27.77

-4.88

Pharmocann Global Semi-Annual Data
	Dec08	Dec09	Jun10	Dec10	Jun11	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT per Share	Get a 7-Day Free Trial															-9.04	-20.74	-0.24	-4.12	-0.44

Pharmocann Global EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Pharmocann Global's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-9.602	/	1.968
=	-4.88

Pharmocann Global's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.901	/	2.033
=	-0.44

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪-4.56

Pharmocann Global (XTAE:PMCN-M) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Pharmocann Global EBIT per Share Related Terms

Thank you for viewing the detailed overview of Pharmocann Global's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmocann Global Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmocann Global Ltd (XTAE:PMCN-M) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ramat Yishai, PO Box 305, Kiryat Tivon, ISR, 3601201

Website

https://www.pharmocann.co.il

Pharmocann Global Ltd is an Israel-based company engaged in producing medical-related cannabis products which include oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains.

Pharmocann Global Headlines

No Headlines